Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: A Pediatric Oncology Group study

David G. Tubergen, Clinton F. Stewart, Charles B. Pratt, William C. Zamboni, Naomi Winick, Victor M. Santana, Zo Anne Dryer, Joanne Kurtzberg, Beverly Bell, Holcombe Grier, Teresa J. Vietti

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Fingerprint Dive into the research topics of 'Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: A Pediatric Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences